Crowdonomics
All companies
CompanionCBD logo

CompanionCBD

Operating

CompanionCBD, Inc.

Retail & Consumer · Scottsdale, AZ · Founded 2018

Manufacturing CBD-based soft chews for the companion animal health market...

Post-money valuation ⓘ
$3.9M
As of Mar 2020 · from Reg CF Offering (2019) · pre-money + amount raised, not a traded price
Total raised
$16,325
Across 1 round since 2019
Latest share price
$1.00
Reg CF · Common Stock · Dec 2019 offering price

Financials

FY2017–FY2018 · from SEC filings · hover any figure for its source
$0
2017
$18K
−$91K
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017 reviewed*
FY2018 reviewed*
Income statement
Revenue
$0
$18,261
Cost of goods sold
$0
$5,074
Gross margin
—
72%
Net income
$0
-$90,675
Taxes paid
$0
$0
Balance sheet
Cash
$0
$67,493
Accounts receivable
$0
$0
Total assets
$0
$154,628
Short-term debt
$0
$6,503
Long-term debt
$0
$0
Total liabilities
$0
$6,503
Other
Headcount
—
3

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$3.9M
pre-money
Reg CF · Common · Dec 2019

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Raised $16.3K / $1.1MInvestors 36Post-money $3.9M

Team

3 people
Brad MalinFounder
Co-Founder, Chief Executive Officer and Director

A serial entrepreneur with 24 years of global sales, branding, marketing, distribution and consulting experience. Brad has worked in a number of different industries, ranging from: medical device, real estate development, biotech/pharmaceutical, environmental and entertainment distribution.

Dr. Josh SosnowFounder
Co-Founder, Chief Medical Officer, Chief Financial Officer and Director

A practicing veterinarian for over 19 years, and advocate for the clinical use of CBD in clinical practice, Dr. Josh Sosnow is a nationally-recognized CBD educator in the veterinary community. His Principal Occupation is President at Sosnow Animal Hospitals, P.C and works with CompanionCBD 50+ hours a week.

Michael Barrett
Chief Operating Officer , Chief Technical Officer, Treasurer

Michael has over 30 years of experience as a software developer both founding and running technical startups in the development and IT spaces. He has been a technical and management leader in the veterinary industry for 15 years.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 7 annual reports (FY2019–FY2025)

Missing: 2019, 2020, 2021, 2022, 2023, 2024, 2025

36 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UOct 7, 20220001665160-22-002708
    EDGAR
  • Form C-UMar 26, 20200001665160-20-000272
    EDGAR
  • Form CDec 20, 20190001665160-19-001235
    EDGAR
Source: ManualCIK 0001794140DEShare price $1.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.